chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tired; Pain in left side of her neck; Pain in left shoulder; Hurt all over; Chills; Feel like she has the flu; Fever; Pain in lower back; This is a spontaneous report from a contactable consumer. This 85-year-old female consumer reported for herself that she received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 Vaccine; Solution for injection; lot number: EN3318; Expiry date: Unknown) via an unknown route of administration in the right shoulder on 01Feb2021 (Monday) as a single dose for COVID-19 immunization.  The patients past medical history includes the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 Vaccine) and patient did not have any side effects at all with the first one. The concomitant medications were not reported.   The patient was okay on Monday. On 02Feb2021 (Tuesday), at 13:00 the patient developed hurt all over, chills, feel like she has the flu, fever. at 18:00, the patient experienced pain in lower back, pain in left shoulder and pain in left side of her neck. On an unknown date, the patient was reportedly  tired. The patient did not receive any treatment. On unknown dates, the body temperature was 101.5 (Tuesday), 99.7 (Wednesday) and 99.0 Degree Centigrade today. The patient has lasting effects of still feeling achy and tired. has lasting effects that she is hurting in her lower back and neck and shoulders now. Later clarified that she is hurting only in her left shoulder. The patient was recovering from the events of hurt all over, feel like she has the flu was recovering. On 02Feb2021, chills recovered. On 04Feb2021, recovered from fever and had not recovered from the events of  pain in lower back and pain in left side of her neck, pain in left shoulder and tired. The patient did not take any other products.  The patient recently had the second dose of the Pfizer vaccine on Monday and does not know how long the bad effects last or what she should do. On Tuesday that she hurt all over, had chills and felt like she had the flu and she was only sick once in her lifetime and that she only had the flu in her early 30s. The patient reported that she was up and about but has a lot of pain in her lower back and the left side of her neck and shoulders she does not feel overall real good. She is a farm girl and knows how to get around. Stated that her daughter saw online not to take Tylenol or anything like that and wanted to know if that is correct.  Occupation/specialty, consent to contact, and email address not provided. The patient did not visit Emergency Room or Physician Office. The patient did not receive any vaccines (within 4 weeks) prior to the first administration date of the suspect vaccines.  No follow-up attempts are possible. No further information is expected.
Severe muscle spasms in lower back, passed out due to pain. No back injury occurred causing spasms. Came on suddenly and would not stop until I went to the emergency room and was treated with muscle relaxers. Has not reoccured since
1 to 2 hours post vaccine administration patient described neurological difficulty while driving her car.  She experienced a headache, dizziness, slight increase in temperature, heaviness in chest.  The dramatic loss of leg and eventually feelings in the arms  brought her to the ER.  She was given IV fluids and IV benedryl.  After 5 hours she was discharged.  Still limited feeling in her legs and arms.  No apparent shortness of breath was observed.  She described it as feeling like being "run over by a truck".  After 24hrs she still complains of sore muscles and joints.  Is now able to stand up and use her hands.
Numbness/tingling ascending from feet to torso; hospitalized and diagnosed with Multiple Sclerosis August 2021
(L) Thigh with redness and swelling from hip to knee. Inconsolable crying for two hours.
The patient's mother brought him back to our clinic about 1 hour and 30 minutes after receiving the MMRV vaccine complaining of itching to his ears, hands, and feet. Upon inspection by APRN, patient had mild redness and welting to the skin around his ears, his arm pits, 2 areas on his anterior chest measuring approximately 2mm in size, one small area on his back, and at the injection site of the MMRV. He did not have any swelling to his mouth, lips, tongue, or throat. APRN prescribed patient oral benadryl and advised to go to an emergency room with any swelling in his mouth or throat.
So on April 19th I got the second Covid vaccine, I went to the urgent care on the following day at approx. 11:30 AM. They did an EKG they said it looked fine and they sent me on my way regardless of it hurting me real bad (my chest). When I woke up Sunday morning, there was a crushing pain in my chest. On the 25th I woke up, got dressed and went right over to the hospital. I was in so much pain I had to go back to the hospital. I was there from the 25th-29th, they said I needed to have an angiogram with a possible stint in my left artery. On the 28th they put that stint in and I left on the 29th of April in the afternoon at about 4pm. I still am not feeling right, my chest hurts not like it did then, but shortness of breath. I also have to take a blood thinner and a baby aspirin. I have new symptoms in both my arms, from my bicep to my triceps is very achy - it has never done that before. My arms are very stiff. I still have trouble taking deep breathes.
headache; felt extremely fatigued; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 25Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "I am a heart patient." (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 26Apr2021, outcome "unknown", described as "felt extremely fatigued"; HEADACHE (non-serious) with onset 28Apr2021, outcome "unknown", described as "headache".  Additional information: The patient took first Covid-19 Vaccine on Sunday, 25Apr2021. On Monday, 26Apr2021, the patient felt extremely fatigued and stayed at home to rest. On Wednesday, 28Apr2021, the patient experienced a headache and stayed home again due to the vaccine. The patient was a heart patient.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Mother called the clinic on 3/12/08, baby started vomiting x 24 hours and just had a diarrhea stool that was bloody.  She was instructed to bring him in to the clinic and arrived within the hour with more episodes of bloody stools.  IV fluids were administered for treatment of dehydration.  Child was admitted to the hospital for treatment after being diagnosed with Intussusception. Hydrostatic Reduction attempts were made but unsuccessful.  Child was then taken to surgery for manual reduction of the intussusception. 5/2/08-ED records received-presented to ED with on and off abdominal pain times 1 week, vomiting with bouts of crying. DX: intussusception. Transferred.  6/2/08-records received for DOS 3/12-3/15/08-DC DX: Intussusception, status post manual reduction and incidental appendectomy. Gastrographin enema. 24 hour period of emesis starting on 3/11/08-became yellow green and developed intermittent colicky episodic abdominal pain with knees posterior to chest or stiffening. Listlessness. Bright red blood in diaper. On 2/27/08 fussy and x-ray of abdomen did not reveal foreign body.
4/23/21- Experienced lip numbness 4/24/21- current - Eyes, cheek, mouth droopy and slurred speech.
Information has been received from an investigator concerning a 12 month old female with nasal congestion and a history of a recent cold and methicillin-resistant staphylococcal aureus infection/abscess x 2 (July 2008 and November 2008) who entered a study. It was reported that the patient does not have a history of seizure, febrile or otherwise. On 10-DEC-2008 the patient was vaccinated S.Q. with a 0.5 ml dose of PROQUAD (Merck) administered in the left arm. Concomitant vaccinations included four 0.50 I.M. doses of MCV4 administered in the right thigh on 06-FEB-2008, 07-APR-2008, 17-JUN-2008 (lot # V59P14) and 10-DEC-2008. Three 0.50 I.M. doses of PEDIARIX administered in the left thigh on 06-FEB-2008, 07-APR-2008 (lot # A021B097AB) and 17-JUN-2008 (lot # A021B097AB). One 0.50 I.M. dose of HAVRIX administered in the left thigh on 10-DEC-2008. Three 0.50 I.M. doses of ACTHIB administered in the left thigh on 06-FEB-2008 (lot # UF214AA), 07-APR-2008 and 17-JUN-2008. Four 0.50 I.M doses of PREVNAR administered in the left thigh on 06-FEB-2008, 07-APR-2008 (lot # B54013K), 17-JUN-2008 (lot # C63111) and 10-DEC-2008. Three oral 2.00 doses of ROTATEQ on 06-FEB-2008, 07-APR-2008 (659915/0015X) and 17-JUN-2008 (lot # 657513/1052U). Other concomitant therapy included hydrocortisone, SULFATRIM, CLEOCIN, HIBICLENS, mupirocin acetaminophen and heparin. On 18-DEC-2008, the patient experienced an apnea episode and was hospitalized at 18:00. It was noted that the patient was taken to the emergency room and eventually admitted to the hospital overnight following an apnea spell at home during a feeding. It was reported that the patient went limp. The patient's aunt gave rescue breaths until the ambulance arrived. After 2 minutes the patient got better and came around and was then acting normally. Once the ambulance arrived, oxygen was given. In the emergency room, the patient had a fever and the doctor could not rule out febrile seizure vs. apparent life-threatening event (ALTE). It was noted that the patient eventually recovered and had no futher distress. Discharge diagnoses apnea or apneic event. The reporting investigator felt that apnea was possibly related to study therapy. The patient's vaccination history included a 0.50 I.M. dose of ENGERIX-B administered in the right thigh on 05-DEC-2007. Additional information is not expected. All available medical records will be provided upon request.
No adverse event; Dose administered after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Sep-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry).    It was unknown if patient had any allergies to medications, food and other products. It was unknown if patient was ever been diagnosed or tested positive for COVID-19. It was unknown if patient had any acute illness at the time of vaccination or a month before vaccination. Not known if patient had any chronic or long standing health conditions.  No concomitant medication was reported.  Patient received Monovalent vaccine. Individual vials of size 5.5 ml. The vial was initially stored in the refrigerator on 20-Sep-2022. The vial did not undergo any temperature excursions.  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Live non-significant follow up received contains: reporter details updated.
Mother reported today (4/8/08) that on 2/27/08 beginning at 11:00 pm the baby began to scream, go to fetal position, hold his head with his hands and arms, raise his arms straight up in the air, refused to be cuddled or comforted.  He fell asleep finally at 5:00 am and was completely normal the next day.
Patient stated she received first Moderna vaccine on 4/22, next day  was tired and sore.  She stated those side effects went away but last Friday she got a red rash on arm that  injection was given in . She denies any other symptoms.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old male patient received BNT162b2 (BNT162B2), on 02Feb2021 as dose 1, single (Lot number: ENS318), in left arm, on 22Feb2021 as dose 2, single (Lot number: EL9264), in left arm and on 09Oct2021 as dose 3 (booster), single (Lot number: FF8839) at the age of 55 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 01Apr2022 as dose 4 (booster), single (Lot number: 6SK21A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "allergy" (unspecified if ongoing), notes: name of drug as reported: no. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jul2022) Negative; (Jul2022) Positive. Therapeutic measures were taken as a result of covid-19.  Clinical Course: Patient received Paxlovid as COVID-19 treatment from 22Jul2022 to 27Jul2022. The patient was not taking any other medications within 2 weeks of starting COVID-19 treatment. COVID relapsed (on 28Jul2022) 2 days after completion of 5 days Paxlovid treatment. No symptoms. Feeling fine, but COVID positive after COVID negative. Relevant past drug history: name of drug as reported: no, reaction: allergy.
how long will the fever last after the shigle shot; how long will the muscle ache last after the shigle shot; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced fever and muscle pain. On an unknown date, the outcome of the fever and muscle pain were unknown.   It was unknown if the reporter considered the fever and muscle pain to be related to Shingrix.  Additional case details were reported as follows: This case was reported by patient himself or herself. The age at vaccination was not reported. The age group was not reported, but was selected as adult as per vaccine indication. The patient enquired how long would the fever and muscle aches last after Shingrix.
Shortly after receiving immunization, tingling, pain and numbness. Nauseated and dizzy for next 2 hours. Increased pain, crying all night. Right deltoid is red hot and hard. Reported by mother.
ACUTE NON ST ELEVATION MI 12/3/2022,  11/2/2022,  11/14/2022,  1/4/2023,  2/14/2023,  1/5/2023  --  RECURRENCE OF                                                                                                             HOSPITALIZATION WITH SAME SYMPTOMS
hearing loss; Drug dose administration interval too short; This case was reported by a pharmacist via call center representative and described the occurrence of hearing loss in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received sometime in May).   In July 2019, the patient received the 2nd dose of Shingrix. In July 2019, less than 2 months after receiving Shingrix, the patient experienced hearing loss (serious criteria GSK medically significant) and drug dose administration interval too short. On an unknown date, the outcome of the hearing loss and drug dose administration interval too short were unknown.   It was unknown if the reporter considered the hearing loss to be related to Shingrix.  Additional details were provided as follows: The reporter had no information regarding lot numbers or expiration dates for the two doses of Shingrix. The patient experienced a sporadic loss of hearing, which she described as her hearing goes in and out. The patient received 2nd dose of Shingrix earlier than the recommended schedule, which led to shortening of vaccination schedule. The patient's doctor had an MRI done. The reporter consented to follow up. It was reported that the patient had not received Shingrix from her pharmacy.
Vaccine was withdrawn from a vial that was punctured 12 hours before then administered to the patient.
Information regarding PREVNAR 13 was received from a healthcare professional regarding a 3-year-old male patient who experienced complained that he could not walk, leg was sore and leg was hot to the touch. At 3 years of age, the patient received a dose in Jul-2010. A couple days after receiving PREVNAR therapy, the patient complained that he could not walk, his leg was sore and leg was hot to the touch in Jul-2010. Patient was advised to take TYLENOL for treatment. Outcome and further details were unknown.
Information has been received from a pharmacist concerning a 65 year old female who on 11-FEB-2009 was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) (no lot number was provided).  Concomitant therapy included CIPRO.  It was reported that on 15-FEB-2009 the patient experienced pain down her left arm and a rash.  The patient sought unspecified medical attention.  Additional information has been requested.
I developed ?covid toes? within 12 hours of vaccine administration. Initially, I experienced pruritis in 3 of my 5 digits on the left foot. This progressed to erythema but then transitioned to significant discomfort and the three effected toes became purple in color. This took nearly 6 weeks to resolve.
12/07 woke up with congestion and extreme fatigue. I assumed that I had COVID-19 due to my husband having tested positive. 12/10 developed cough. Congestion and fatigue continued for 3 days and cough lasted a week. Took MUCINEX, DAYQUIL, and NYQUIL and all helped to relieve symptoms.
Reported blurry vision, dry mouth.  HTN 170-200/90-110,   Did not take her BP medication or eat this morning.  She normally takes her BP med at night.  EMT evaluation. Given juice and water.  BP 185/98,  reports no further blurry vision. MD evaluated.  BP  160/88 by paramedic.   Patient released home,  will call her primary physician and seek immediate care if symptoms recur
E. multiforme rash in palms and plantar feet, with right ankle swelling - 8 days after HEB B #4 and HEB A# 1 given.
Swollen, redness, hardness and hot on vaccination site 1 1/2 inches around vaccination site, 24 hours after vaccination.
My daughter had the Pfizer covid vaccine. Several days after receiving the vaccine she complained of muscle soreness but felt soreness was from exercising (but after speaking with those that were with her, she didn't do anything to overdo to cause the the kind of soreness as far as severity). At the time she dismissed it and then on 9/15/21 she was found unresponsive. She was immediately taken to the ER where they found her CK numbers were elevated at over 13000 and diagnosed her with Rhabdomyolysis. She was still at this time complaining of severe soreness, headache, and at the time she was found she was suffering memory loss. The next day her CK numbers went up over 17000. It was not till Saturday her numbers went down to 7000. They treated her with fluids during her inpatient stay and she was released home to my care 9/18/21. They did every test they could do to determine any underlying health conditions and have ruled EVERYTHING out. The only new product her body was exposed to was the Pfizer Covid vaccine. She has mostly recovered but still suffering a lot of memory loss for the last 2 months. If test and additional info is needed you can contact us directly.
Started with fever and body aches almost 12 hours after vaccine, then a few hours later head ache and nausea.  3 days after vaccine noticed chest pain and shortness of breath.  5 days after vaccine started feeling stinging pains at injection spot. 6 days later stinging pain has spread to my legs.
Patient stated that they felt "light-headed and had hot flashes" about 10 minutes after vaccine administration. No transport was needed, and patient recovered shortly and walked out of the clinic.
2.5 months after my booster vaccine I woke with the left side of my face distorted.  I went to an urgent care where they diagnosed me with Bells Palsy.
Rash on abdomen & chest. Patient took 50mg BENADRYL PO on 06/07/11 at onset of symptoms. Patient came in for a 1mL steroid inj and 25ml of Diphenhydramine injection on 06/08/11 at 10:30am.
1 week S/P injection developed flat red rash beginning at injection site and spread over most of upper arm
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB lot # M046373, expiration date 04-NOV-2018 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 49 degrees Fahrenheit to for 12 hours. Data logger was involved. There were some previous temperature excursion of 57 degrees Fahrenheit to for 4 hours. This is one of two reports received from the same reporter. ; Sender's Comments: US-009507513-1709USA014163:
recently dc'd from hosp for COVID pneumonia and hypoxic respiratory failure to SNF; on 3 L O2 via NC; began to have worsening SOB and hypoxia; placed on NRB mask with O2 sats improvement between 80-96%; EMS contacted and transported to ED; in ED pt experienced A Fib with rapid Ventricular response; Cardizem given; transferred to ICU; fluid overload due to diastolic dysfunction; COVID fibrosis; treated with steroids and antibiotics; pt's condition worsened; family transitioned pt to comfort care and he passed away in the hosp